ConductScience.org, home

Paper35898243

Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report.

Sebastian J and 3 others. Hosp Pharm, 2022. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report. Papers, record 35898243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35898243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report.
PubMed
Journal
Hosp Pharm
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2023-08-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sebastian JJunyhttps://orcid.org/0000-0002-4626-8729
2Mathew MMerrinhttps://orcid.org/0000-0002-6354-2312
3Sharsty VVeeranna
4Ramesh MMadhan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124981218Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota.Mayo Clin Proc2014https://conductscience.org/library/papers/24981218PubMed
223238161Hypersensitivity and vaccines: an update.Eur J Dermatol2013https://conductscience.org/library/papers/23238161PubMed
332684499Planning for COVID-19 vaccines safety surveillance.Vaccine2020https://conductscience.org/library/papers/32684499PubMed
433713282Diagnosis and management of leukocytoclastic vasculitis.Intern Emerg Med2021https://conductscience.org/library/papers/33713282PubMed
521391523Systemic vasculitis.Am Fam Physician2011https://conductscience.org/library/papers/21391523PubMed
633034449COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.ACS Nano2020https://conductscience.org/library/papers/33034449PubMed
726398442Vasculitis as an adverse event following immunization - Systematic literature review.Vaccine2016https://conductscience.org/library/papers/26398442PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40365256Cutaneous small vessel vasculitis in the COVID-19 era: a systematic review.Skin Health Dis2025https://conductscience.org/library/papers/40365256PubMed
39224893COVID-19 vaccine-associated vasculitis: A systematic review.SAGE Open Med2024https://conductscience.org/library/papers/39224893PubMed
37641637Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital.Ther Adv Vaccines Immunother2023https://conductscience.org/library/papers/37641637PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35898243

GET https://conductscience.org/api/papers/v1/35898243/authors